This page is for healthcare professionals only.
A Galapagos product may be discussed at these events.
The annual EULAR European Congress of Rheumatology is the most anticipated event in the rheumatology calendar. The EULAR 2023 scientific programme includes a wide range of sessions presented by some of the world’s leading specialists exploring basic science, traditional medicine and clinical practice, as well as a wealth of important new data!
Galapagos is proud to be a sponsor at EULAR 2023 and to be hosting a satellite symposium and consult-the-expert session. We look forward to meeting you at EULAR 2023!
Don’t miss out! Join us at EULAR to gain insights from these experts and ask them your questions.
Don’t miss out! Join us at EULAR 2023 to meet these experts and take part in the discussion.
Posters are available as soon as they are presented at EULAR (please see presentation times below).
Galapagos driven abstracts
Posters are available as soon as they are presented at EULAR (please see presentation times below).
The EULAR European Congress of Rheumatology is the main event in the global rheumatology calendar.
GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos NV.
© 2023 Galapagos NV. All rights reserved
GL-RA-FIL-202304-00003 | April 2023
© Copyright 2021 Galapagos NV
You are about to leave this website and will be redirected to an external website. We are not responsible of that external website’s content. By continuing, you confirm that you have taken note of this.
Forgot your PIN? Send an email to omnichannel@glpg.com to retrieve your PIN.
GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos
NV.
© 2022 Galapagos NV. All rights reserved.
GL-RA-FIL-202104-00008 12/22
© Copyright 2021 Galapagos NV
Forgot your PIN? Send an email to omnichannel@glpg.com to retrieve your PIN.
You are about to leave this website and will be redirected to an external website. We are not responsible of that external website’s content. By continuing, you confirm that you have taken note of this.